Page 12 - பின் கதவு வழி க்கு ப்ராஃபிட் இருந்து இன்று News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sio Gene Therapies, Inc. (NASDAQ:SIOX)’s traded shares stood at 451,895 during the last session, with the company’s beta value hitting 1.7. At the close of trading, the stock’s price was $2.53, to imply an increase of 3.69% or $0.09 in intraday trading. The SIOX share’s 52-week high remains $5.74, putting it -126.88% down since that peak but still an impressive +26.48% since price per share fell to its 52-week low of $1.86. The company has a valuation of $146.2 Million, with an average of 834.2 Million shares in intraday trading volume over the past 10 days and average of 1.58 Million shares over the past 3 months. Analysts have given a consensus recommendation of Buy for Sio Gene Therapies, Inc. (SIOX), translating to a mean rating of 1.3. Of 3 analyst(s) looking at the stock, none analyst(s) give SIOX a Sell rating. 1 of those analysts rate the stock as Overweight while no one advise Hold as 2 recommend it as a Buy. None analyst(s) have given it an Underweight rating. Esti

Vanguard total stock market index fundDelaware group equity fds healthcare fundSio gene therapies incSio gene therapiesGene therapiesWall streetConsonance capital managementRubric capital managementBackdoor way to profit from todayCrypto bull marketDelaware group equity fdsDelaware healthcare fundMutual fundsNasdaq sioxIo gene therapies inc sioxIox stock